Enfermedad pulmonar intersticial fibrosante progresiva (EPI-FP)

 

Reduced Decline in Forced Vital Capacity in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases (ILDs) Treated with Nintedanib

Matteson EL et al.
 

Acceder

Effects of Nintedanib in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases (ILDs) in the INBUILD Trial: Subgroups by HRCT Pattern

Dellaripa PF et al.
 

Acceder

¿Te ha resultado útil esta información?